A Study of Chinese Congenital Bicuspid Aortic Valve
ConditionBicuspid Aortic Valve (BAV)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-60
SponsorRuijin Hospital
About this trial
Pervious studies indicated that the prevalence of bicuspid aortic valve（BAV） might be higher in China. There is a familial predisposition to the development of BAV. The study analyzed epidemiological data on selected BAV and established a BAV cohort to observe disease progression and treatment outcomes.
Eligibility criteria
Qualifiers
The patients were aged 14-60 years;
Definitive diagnosis of BAV by imaging (echocardiography, aortic CTA, cardiac magnetic resonance, etc.)
Patients were informed about the nature of the study and agreed to participate in all the terms of the study and signed an informed consent form approved by the ethics committee.
Disqualifiers
Poor patient compliance and inability to complete follow-up visits as required;
Rheumatic heart valve disease, other organic valve disease.
Hyperthyroidism, severe anemia, and other factors that significantly affect hemodynamics.
Other circumstances that the researcher believes should be excluded.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov